Phospho-LCK (Tyr505) Antibody

What is the biological significance of LCK phosphorylation at Tyr505?

Phosphorylation of LCK at tyrosine 505 (Tyr505) serves as a critical negative regulatory mechanism in T cell signaling. This site is phosphorylated by C-terminal Src kinase (Csk) and creates an inhibitory conformation that downregulates LCK's catalytic activity . When phosphorylated, Tyr505 interacts with LCK's own SH2 domain, causing an intramolecular arrangement that prevents interactions with other proteins . This inhibitory phosphorylation maintains LCK in an inactive state in resting T cells, preventing inappropriate T cell activation. The regulation of this site is essential for proper T cell development and function, as demonstrated by studies showing that mice lacking LCK expression exhibit significant defects in T cell development and activity .

How does the phosphorylation status of LCK Tyr505 change during T cell activation?

During T cell activation, the phosphorylation dynamics at Tyr505 play a crucial role in regulating LCK activity:

In resting T cells, approximately 20% of LCK molecules exist with phosphorylated Tyr505 . Upon T cell receptor (TCR) engagement, CD45 phosphatase activity leads to dephosphorylation of Tyr505, releasing LCK from its inhibitory conformation . This allows LCK to phosphorylate the intracellular chains of CD3 and zeta chains of the TCR complex, initiating the signaling cascade . Interestingly, partial segregation of CD45 from LCK during TCR activation may favor dephosphorylation at Tyr505 while reducing dephosphorylation of the activating Tyr394 site, promoting optimal LCK activity .

What techniques are available for detecting LCK phosphorylated at Tyr505?

Multiple analytical approaches can be employed to detect and quantify LCK phosphorylated at Tyr505:

Each method offers distinct advantages depending on experimental requirements. Flow cytometry provides single-cell resolution but requires specific fixation and permeabilization protocols . Western blotting allows detection of total protein levels alongside phosphorylation status . ELISA and AlphaLISA approaches offer higher throughput options with quantitative readouts for cellular lysates .

What are the recommended controls when using Phospho-LCK (Tyr505) antibodies?

Proper experimental controls are essential for reliable phospho-LCK (Tyr505) detection:

• Positive controls: Jurkat cells (human T lymphocyte line) serve as ideal positive controls as they express high levels of LCK and exhibit detectable Tyr505 phosphorylation under basal conditions .

• Negative controls:

  • Isotype-matched control antibodies to assess non-specific binding

  • Cell lines lacking LCK expression

  • Dephosphorylation controls (samples treated with phosphatases)

• Specificity controls:

  • Peptide competition assays with phosphorylated and non-phosphorylated peptides

  • Comparison with other phospho-specific antibodies targeting different LCK sites

• Treatment controls:

  • TCR stimulation (decreases Tyr505 phosphorylation)

  • Csk overexpression (increases Tyr505 phosphorylation)

  • CD45 inhibition (increases Tyr505 phosphorylation)

These controls help validate antibody specificity and ensure accurate interpretation of experimental results across different detection platforms.

How do Phospho-LCK (Tyr505) antibodies differ in specificity and applications?

Different Phospho-LCK (Tyr505) antibody clones and formats are optimized for specific applications:

The SRRCHA monoclonal antibody is particularly well-characterized for flow cytometry applications, with validated protocols for intracellular staining . The E3Z5E recombinant antibody offers advantages for Western blotting with superior lot-to-lot consistency . Selection should be based on the intended application, required sensitivity, and species reactivity needs.

How can I optimize flow cytometric analysis using Phospho-LCK (Tyr505) antibodies?

Optimizing flow cytometric detection of phospho-LCK (Tyr505) requires careful attention to several methodological factors:

• Fixation and permeabilization:

  • Use the Intracellular Fixation & Permeabilization Buffer Set (e.g., Product # 88-8824-00) for optimal results

  • Follow the two-step protocol for intracellular (cytoplasmic) proteins to maintain both surface marker integrity and intracellular epitope accessibility

• Antibody titration:

  • Start with recommended concentration of 5 μL (0.125-0.25 μg) per test in 100 μL final volume

  • Empirically determine optimal cell numbers (range from 10^5 to 10^8 cells/test)

• Fluorophore selection:

  • PE-conjugated antibodies (excitation: 488-561 nm; emission: 578 nm) work with blue, green, or yellow-green lasers

  • eFluor 660 (excitation: 633 nm; emission: 659 nm) requires red laser capability

  • Consider spectral overlap with other markers in your panel

• Signal amplification and background reduction:

  • Block Fc receptors prior to staining

  • Include unstained, single-stained, and FMO (fluorescence minus one) controls

  • Use multiple wash steps to reduce non-specific binding

• Stimulation protocols:

  • Compare phosphorylation levels in resting cells versus TCR-stimulated cells

  • Include positive controls such as stimulated normal human peripheral blood cells

This methodological approach maximizes sensitivity while minimizing background, allowing for accurate detection of physiologically relevant changes in Tyr505 phosphorylation status.

What are the critical factors for Western blot optimization when detecting Phospho-LCK (Tyr505)?

Successful Western blot detection of phospho-LCK (Tyr505) requires attention to several technical considerations:

• Sample preparation:

  • Rapid lysis in the presence of phosphatase inhibitors is crucial to preserve phosphorylation status

  • Include protease inhibitors to prevent degradation

  • Standardize protein loading (15-30 μg total protein per lane is typically sufficient)

• Antibody selection and dilution:

  • Use validated antibodies at recommended dilutions (typically 1:1000 for Western blotting)

  • Consider recombinant antibodies for improved lot-to-lot consistency

• Detection optimization:

  • Expected molecular weight for LCK is approximately 56 kDa

  • Blocking with 5% BSA (rather than milk) often improves phospho-epitope detection

  • Extended primary antibody incubation (overnight at 4°C) may enhance sensitivity

• Controls:

  • Include positive control lysates (e.g., Jurkat cells)

  • Run parallel blots for total LCK to calculate phospho/total ratios

  • Consider phosphatase-treated samples as negative controls

• Troubleshooting common issues:

  • High background: Increase blocking time, optimize antibody dilution

  • Weak signal: Increase protein loading, extend exposure time, enhance signal with alternative detection systems

  • Multiple bands: Validate with immunoprecipitation to confirm specificity

These methodological refinements help ensure specific detection of phospho-LCK (Tyr505) while minimizing artifacts and background issues.

How can different assay platforms for Phospho-LCK (Tyr505) detection be compared and validated?

Cross-platform validation enhances confidence in phospho-LCK (Tyr505) quantification:

For cross-platform validation:

• Correlation analysis: Test identical samples across multiple platforms and calculate correlation coefficients

• Standardization: Include common positive and negative controls across all platforms

• Biological validation: Confirm that known biological modulators (e.g., TCR stimulation, CD45 inhibition) produce expected results across platforms

• Dynamic range assessment: Determine the linear detection range for each platform using dilution series

• Reproducibility testing: Evaluate intra- and inter-assay variability for each method

This comprehensive validation approach helps researchers select the most appropriate detection method for their specific experimental questions while ensuring confidence in the data generated.

How does the regulatory interplay between Tyr505 and other LCK phosphorylation sites affect experimental design?

LCK activity is regulated by multiple phosphorylation sites that interact in complex ways:

This complex regulatory network has important implications for experimental design:

• Dual phosphorylation analysis: Consider measuring both Tyr505 and Tyr394 phosphorylation to fully characterize LCK activation state

• Kinetic studies: Temporal dynamics of phosphorylation/dephosphorylation are critical, with rapid changes occurring during T cell activation

• Spatial considerations: Membrane microdomains (lipid rafts) affect LCK regulation, with PAG/Cbp raft-associated protein recruiting Csk to phosphorylate Tyr505

• CD45 gradient effects: CD45 has a dual role, dephosphorylating both the inhibitory Tyr505 and the activating Tyr394, with concentration-dependent effects

• Experimental interventions:

  • Csk inhibitors/knockdown will reduce Tyr505 phosphorylation

  • CD45 inhibitors will increase Tyr505 phosphorylation but may also affect Tyr394

  • Membrane-targeting domain modifications can alter localization and phosphorylation status

Understanding this interconnected regulatory network allows for more sophisticated experimental designs that capture the complexity of LCK regulation in T cell signaling.

What are the methodological approaches for studying spatial organization of Phospho-LCK (Tyr505) in T cells?

Investigating the spatial distribution of phospho-LCK (Tyr505) requires specialized techniques that preserve spatial information:

• Immunofluorescence microscopy:

  • Fixed-cell approaches using phospho-specific antibodies

  • Co-staining with markers for membrane microdomains (e.g., cholera toxin B for lipid rafts)

  • Analysis of co-localization with TCR, CD4/CD8, and other signaling components

• Proximity ligation assays (PLA):

  • Detect interactions between phospho-LCK (Tyr505) and its binding partners

  • Provides spatial resolution beyond conventional co-localization studies

  • Can detect conformational changes associated with Tyr505 phosphorylation

• Live-cell imaging approaches:

  • Phospho-specific biosensors based on fluorescence resonance energy transfer (FRET)

  • Correlation with TCR microcluster formation using total internal reflection fluorescence (TIRF) microscopy

• Super-resolution microscopy:

  • Techniques like STORM or PALM provide nanoscale resolution of phospho-LCK distribution

  • Can resolve distribution within membrane nanodomains below the diffraction limit

• Biochemical fractionation:

  • Isolation of detergent-resistant membrane fractions (lipid rafts)

  • Analysis of phospho-LCK (Tyr505) distribution between soluble and membrane-associated pools

  • Examination of PAG/Cbp-associated Csk localization that regulates Tyr505 phosphorylation

These methodological approaches can reveal how the spatial organization of phospho-LCK (Tyr505) contributes to the regulation of T cell signaling, particularly in the context of immunological synapse formation and TCR signaling complexes.

How can phospho-LCK (Tyr505) analysis be incorporated into multi-parameter immune phenotyping?

Integration of phospho-LCK (Tyr505) detection into comprehensive immune phenotyping workflows:

• Multiparameter flow cytometry strategies:

  • Surface marker panel suggestions:

    • T cell identification: CD3, CD4, CD8

    • Activation status: CD69, CD25, CD44, CD62L

    • Memory/naive subsets: CCR7, CD45RA/RO

  • Compatible fluorophores for phospho-LCK (Tyr505): PE or eFluor 660

  • Sample acquisition recommendation: minimum of 50,000 events in the T cell gate

• Mass cytometry (CyTOF) integration:

  • Metal-conjugated phospho-LCK (Tyr505) antibodies

  • Simultaneous detection of multiple phospho-epitopes in signaling pathways

  • Clustering algorithms to identify cellular subsets with distinct phosphorylation patterns

• Protocol optimization for multi-parameter analysis:

  • Sequential staining: surface markers → fixation/permeabilization → intracellular phospho-epitopes

  • Buffer compatibility testing to maintain epitope integrity

  • Careful fluorophore selection to minimize spectral overlap

• Data analysis considerations:

  • Phospho-flow gating strategies should account for shifts in fluorescence intensity

  • Normalization to unstimulated controls for each cell subset

  • Dimensionality reduction techniques (tSNE, UMAP) for visualization of complex datasets

• Experimental design:

  • Time-course analysis to capture phosphorylation dynamics

  • Dose-response studies with TCR stimulation or inhibitors

  • Integration with functional readouts (cytokine production, proliferation)

This multi-parameter approach allows researchers to correlate phospho-LCK (Tyr505) status with cellular phenotype, activation state, and functional outputs, providing a comprehensive view of T cell signaling in health and disease.

What are the current challenges and emerging solutions in quantifying Phospho-LCK (Tyr505) in primary T cells?

Researchers face several challenges when quantifying phospho-LCK (Tyr505) in primary T cells:

Emerging methodological solutions include:

• Single-cell phospho-proteomics:

  • Integration with transcriptomics for correlation of phosphorylation with gene expression

  • Microfluidic approaches for miniaturized analysis of limited samples

• In situ detection approaches:

  • Tissue section analysis with multiplexed immunofluorescence

  • Spatial transcriptomics combined with phospho-protein detection

• Computational methods:

  • Machine learning algorithms for automated identification of phosphorylation patterns

  • Network analysis to integrate phospho-LCK (Tyr505) status with downstream signaling events

• Protocol enhancements:

  • Optimized fixation buffers that better preserve physiological phosphorylation states

  • Phosphatase inhibitor cocktails tailored to T cell signaling pathways

• Validation frameworks:

  • Integration of multiple detection platforms for cross-validation

  • Development of standardized control samples for inter-laboratory reproducibility

These methodological advances are helping overcome the technical challenges associated with accurate quantification of phospho-LCK (Tyr505) in primary T cells, enabling more physiologically relevant insights into T cell signaling dynamics.